Press Release
Superseding Indictment Filed Against Boise Doctor Charged With Controlled Substance Delivery
For Immediate Release
U.S. Attorney's Office, District of Idaho
BOISE – A federal grand jury in Boise yesterday returned a superseding indictment against Michael Minas, 49, of Boise, Idaho, charging him with 112 counts of distributing a controlled substance, U.S. Attorney Wendy J. Olson announced.
The superseding indictment alleges that Minas distributed oxycodone 30 mg and Oxycontin 80 mg, both Schedule II controlled substances, and diazepam, a Schedule IV controlled substance, and that he did so outside the usual course of professional practice and not for a legitimate medical purpose. The original indictment charged seventeen counts of distributing a controlled substance, related to three patients. The superseding indictment adds nine additional patients, for a total of 112 counts.
Since the initial indictment, Minas has been released pending trial, currently scheduled for December 16, 2014. Pending trial, Minas has been prohibited from writing prescriptions and from engaging in the practice of medicine except for the limited purpose of transferring patient records so that patients may see other providers. He also was required to relinquish any prescription pads in his possession.
The charge of distributing a controlled substance is punishable by up to twenty years in prison, a maximum fine of $1,000,000.00 and at least three years of supervised release.
The case was investigated by the Drug Enforcement Administration (DEA) led Tactical Diversion Squad which is comprised of law enforcement personnel from the DEA, Ada County Sheriff’s Office, Boise Police Department, Idaho State Police, Meridian Police Department, Nampa Police Department and U.S. Department of Health and Human Services Office of Inspector General.
An indictment is a means of charging a person with criminal activity. It is not evidence. The person is presumed innocent until proven guilty beyond a reasonable doubt in a court of law.
Updated December 15, 2014
Component